[Federal Register: March 30, 2005 (Volume 70, Number 60)]
[Notices]
[Page 16290]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30mr05-92]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Preventing Maternal and Neonatal Bacterial Infections in
Developing Settings With a High Prevalence of HIV: Assessment of the
Disease Burden and Evaluation of an Affordable Intervention in Soweto,
South Africa; Notice of Intent To Fund Single Eligibility Award
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
intent to fund fiscal year (FY) 2005 funds for a cooperative agreement
program to conduct a clinical trial to evaluate the efficacy of
chlorhexidine vaginal wipes during labor at preventing perinatal and
maternal post-partum sepsis in an African setting with a high
prevalence of maternal HIV infection. In conjunction with this trial,
risk factors for serious neonatal and maternal peripartum infections
will be evaluated, with an emphasis on the impact of maternal HIV
infection on these outcomes. Prospective maternal and neonatal
infections surveillance will also be established to characterize the
burden of disease. The Catalog of Federal Domestic Assistance number
for this program is 93.283.
B. Eligible Applicant
Assistance will be provided only to the Respiratory and Meningeal
Pathogens Unit of the Medical Research Council of South Africa. No
other applications are solicited.
The Respiratory and Meningeal Pathogens Unit is the only
institution that possesses the requisite scientific and technical
expertise, the infrastructure capacity and experience and collaborative
relationships necessary to conduct the described research topics and to
ensure that all aspects of this agreement can be fulfilled. The Unit
has already been a single eligibility recipient of a cooperative
agreement for this activity and is midway through completion of this
activity. This RFA will allow for completion of the activity.
C. Funding
Approximately $800,000 is available in FY 2005 to fund this award.
It is expected that the award will begin on or before August 31, 2005,
and will be made for a 12-month budget period within a project period
of up to five years. Funding estimates may change.
D. Where To Obtain Additional Information
For general comments or questions about this announcement, contact:
Technical Information Management, CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
For program issues, contact: Trudy Messmer, Scientific Review
Administrator, 1600 Clifton Road, MS C-19, Atlanta, GA 30333,
Telephone: (404) 639-3770, E-mail: TMessmer@cdc.gov.
Dated: March 24, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-6257 Filed 3-29-05; 8:45 am]
BILLING CODE 4163-18-P